
OnKure Therapeutics, Inc. — Investor Relations & Filings
OnKure Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the discovery and development of precision medicines for cancer patients. The company is building a pipeline of potentially best-in-class, tumor-agnostic therapies that target biologically validated drivers of cancers, particularly those underserved by current treatments. Its research and development efforts are centered on novel and potentially less toxic kinase inhibitor drugs and epigenetic therapies.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| S-3 - OnKure Therapeutics, Inc. (0001637715) (Filer) | 2026-04-24 | English | |
| 8-K - OnKure Therapeutics, Inc. (0001637715) (Filer) | 2026-03-30 | English | |
| 4 - OnKure Therapeutics, Inc. (0001637715) (Issuer) | 2026-03-24 | English | |
| 4 - OnKure Therapeutics, Inc. (0001637715) (Issuer) | 2026-03-24 | English | |
| SCHEDULE 13G Filing | 2026-02-17 | English | |
| SCHEDULE 13G/A Filing | 2026-02-17 | English |
Browse filings by year
9 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
9 filings
| |||||
| 36258748 | S-3 - OnKure Therapeutics, Inc. (0001637715) (Filer) | 2026-04-24 | English | ||
| 33086632 | 8-K - OnKure Therapeutics, Inc. (0001637715) (Filer) | 2026-03-30 | English | ||
| 33035819 | 4 - OnKure Therapeutics, Inc. (0001637715) (Issuer) | 2026-03-24 | English | ||
| 33035817 | 4 - OnKure Therapeutics, Inc. (0001637715) (Issuer) | 2026-03-24 | English | ||
| 31048892 | SCHEDULE 13G Filing | 2026-02-17 | English | ||
| 31048890 | SCHEDULE 13G/A Filing | 2026-02-17 | English | ||
| 31048889 | SCHEDULE 13G/A Filing | 2026-02-17 | English | ||
| 12862905 | 4 | 2026-01-02 | English | ||
| 12862904 | Director's Dealing 2026 | 2026-01-02 | English | ||
|
2025
6 filings
| |||||
| 12862906 | Director's Dealing 2025 | 2025-12-23 | English | ||
| 12862907 | Director's Dealing 2025 | 2025-12-23 | English | ||
| 12862908 | Major Shareholding Notification 2025 | 2025-11-28 | English | ||
| 12862909 | 424B3 | 2025-11-21 | English | ||
| 12862910 | Regulatory Filings 2025 | 2025-11-19 | English | ||
| 12862913 | POS AM | 2025-11-06 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
89bio, Inc.
Clinical-stage biopharma developing therapies for liver and…
|
ETNB | US | Manufacturing |
|
Aardvark Therapeutics, Inc.
Clinical-stage biopharma developing therapeutics for hunger…
|
AARD | US | Manufacturing |
|
Aarey Drugs & Pharmaceuticals Ltd
Manufactures APIs and chemical intermediates for global pha…
|
AAREYDRUGS | IN | Manufacturing |
|
Aarti Drugs Limited
Produces APIs, pharma intermediates, and specialty chemical…
|
AARTIDRUGS | IN | Manufacturing |
|
Aarti Pharmalabs Limited
Manufacturer of APIs, intermediates, and xanthines with glo…
|
AARTIPHARM | IN | Manufacturing |
|
AAYUSH WELLNESS LIMITED
Develops and markets herbal formulations, supplements, and …
|
539528 | IN | Manufacturing |
|
Ab&B Bio-Tech CO., LTD. JS
Biopharmaceutical company engaged in the R&D and commercial…
|
2627 | HK | Manufacturing |
|
Abbisko Cayman Limited
Clinical-stage biopharma focused on discovering and develop…
|
2256 | KY | Manufacturing |
|
Abbott India Ltd.
Provides pharmaceutical solutions in gastroenterology, card…
|
ABBOTINDIA | IN | Manufacturing |
|
ABBOTT LABORATORIES
Global healthcare company in medical devices, diagnostics, …
|
ABT | US | Manufacturing |
OnKure Therapeutics, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34730/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34730 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34730 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34730 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34730}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for OnKure Therapeutics, Inc. (id: 34730)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.